Synergy Pharmaceuticals LLCSGYPQ
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Synergy Pharmaceuticals LLC (SGYPQ) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was 1620 Investment Advisors, Inc. ($0).
- Company
- Synergy Pharmaceuticals LLC
- CUSIP
- 871639308
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| 1620 Investment Advisors, Inc. | 0.00% | No change | 25 | $0 |
"% of holder's portfolio" is SGYPQ's weight in each manager's 13F, not the share of Synergy Pharmaceuticals LLC the manager owns.